From: Exosome-derived proteins in gastric cancer progression, drug resistance, and immune response
Protein | Biofluid | Detection mode | Progression | Prognosis | Refs. |
---|---|---|---|---|---|
PD-L1 | Serum | ELISA | NA | PFS | [81] |
PD-L1 | Serum | ELISA | NA | OS | [71] |
FZD10 | Plasma | Western blotting | TNM stage | NA | [83] |
FZD10 | Plasma | Western blotting | NA | NA | [84] |
NNMT | Peritoneal fluid | Western blotting | Peritoneal carcinomatosis | NA | [34] |
CD14 | Plasma | Nano-HPLC–MS/MS | Peritoneal metastasis | NA | [85] |
ILK1 | Plasma | Nano-HPLC–MS/MS | Hepatic metastasis | NA | [85] |
CD44 | Serum | ELISA | LNM | NA | [86] |
Wnt5a | Serum | ELISA | LNM | NA | [87] |
TGF-β1 | Plasma | ELISA | TNM stage LNM | NA | [74] |
HER2 | Serum | ELISA | NA | NA | [90] |